Login to Your Account



Zai has arrived; inks deal with Sanofi for preclinical COPD drugs

By Shannon Ellis
Staff Writer

Friday, August 22, 2014
SHANGHAI – Newly minted Zai Lab Ltd., of Shanghai, has made its eagerly awaited debut announcement, obtaining global rights to two Sanofi SA preclinical compounds for chronic respiratory diseases.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription